APA (7th ed.) Citation

Cho, Y., Kim, B. H., Kim, T. H., Koh, Y. H., & Park, J. (2022). Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: A complete response case according to modified RECIST criteria. Korean Liver Cancer Association.

Chicago Style (17th ed.) Citation

Cho, Yuri, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, and Joong-Won Park. Sorafenib Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Portal and Hepatic Vein Invasion Extending to the Inferior Vena Cava: A Complete Response Case According to Modified RECIST Criteria. Korean Liver Cancer Association, 2022.

MLA (9th ed.) Citation

Cho, Yuri, et al. Sorafenib Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Portal and Hepatic Vein Invasion Extending to the Inferior Vena Cava: A Complete Response Case According to Modified RECIST Criteria. Korean Liver Cancer Association, 2022.